Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
1.770
+0.140 (8.54%)
Nov 21, 2024, 3:49 PM EST - Market open
Iterum Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 40 | 26 | 10 | 72 | 49 | 67 | |
| Market Cap Growth | 136.93% | 157.57% | -85.65% | 47.53% | -27.45% | -5.68% | |
| Enterprise Value | 45 | 11 | -22 | 16 | 86 | 59 | |
| Last Close Price | 1.63 | 1.97 | 0.84 | 5.88 | 14.83 | 67.50 | |
| PS Ratio | - | - | - | - | - | 1808.39 | |
| PB Ratio | -2.15 | -4.13 | 0.37 | 1.43 | -0.96 | -2.55 | |
| P/TBV Ratio | - | - | 0.39 | 1.53 | - | - | |
| EV/Sales Ratio | - | - | - | - | - | 1587.12 | |
| Debt / Equity Ratio | -1.95 | -3.05 | 1.08 | 0.61 | -0.95 | -0.79 | |
| Asset Turnover | - | - | - | - | - | 0.00 | |
| Quick Ratio | - | 1.79 | 6.75 | 6.38 | 0.49 | 0.19 | |
| Current Ratio | - | 1.89 | 6.89 | 6.43 | 0.51 | 0.32 | |
| Return on Equity (ROE) | - | -355.35% | -113.59% | - | - | -454.48% | |
| Return on Assets (ROA) | -59.42% | -63.74% | -23.99% | -24.67% | -68.59% | -103.16% | |
| Return on Capital (ROIC) | -95.65% | -83.33% | -27.37% | -39.23% | - | -158.94% | |
| Earnings Yield | -82.55% | -144.97% | -432.40% | -127.86% | -107.14% | -154.13% | |
| FCF Yield | -148.65% | -180.37% | -22.21% | -112.36% | -122.47% | |
| Buyback Yield / Dilution | -28.02% | -5.93% | -12.35% | -580.42% | -65.38% | -66.22% | |
| Total Shareholder Return | -28.02% | -5.93% | -12.35% | -580.42% | -65.38% | -66.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.